Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benefits of SNMC for Heptoma Patient With Acute Hepatitis Post TACE
NCT04015245Phase 4Completed
- Sponsor
- Chi Mei Medical Center
- Start
- Apr 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of glycyrrhiza glabra in hepatocellular carcinoma (HCC), hepatitis, sponsored by Chi Mei Medical Center. Started Apr 2018; status: completed.
02
Drugs
glycyrrhiza glabra
03
Conditions
hepatocellular carcinoma (HCC)hepatitis
Beyond the preview
Go deeper on NCT04015245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04015245.